Skip to main content
Clinical Trials/NCT03041168
NCT03041168
Terminated
Not Applicable

Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors

Thomas Jefferson University1 site in 1 country414 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carotid Artery Disease
Sponsor
Thomas Jefferson University
Enrollment
414
Locations
1
Primary Endpoint
Difference between percent carotid artery stenosis measured by CSS and by carotid ultrasound
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The proposed study is evaluating a novel technology, Carotid Stenotic Scan (CSS), developed by the sponsor, CVR Global. Study Design. This is a prospective cohort study that will compare a new application of a technology, the CSS device, to reference standards for assessment of carotid disease.

Detailed Description

The overall objectives of this study are to demonstrate that the Carotid Stenotic Scan (CSS) can accurately detect significant carotid artery stenosis. Secondary objective is to relate changes in CSS signal to different degrees of stenosis. We obtain a "proof of concept" if the device correlates strongly with the established classification of atherosclerotic carotid disease derived various imaging modalities including magnetic resonance angiography (MRA) and computer tomographic angiography (CTA), conventional angiography, or carotid ultrasound.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
March 15, 2018
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects over 18 referred for carotid duplex ultrasound.
  • Subjects over 18 referred for CT angiography, MR angiography, or conventional angiography of the carotid arteries

Exclusion Criteria

  • Previous history of carotid endarterectomy, carotid artery stent
  • Previous surgery involving the neck (including thyroidectomy or parathyroidectomy)
  • Patients with prosthetic heart valve
  • Patients unable to provide informed consent.

Outcomes

Primary Outcomes

Difference between percent carotid artery stenosis measured by CSS and by carotid ultrasound

Time Frame: CSS reported percentage of carotid stenosis within 30 days of carotid ultrasound

Secondary Outcomes

  • Difference between percent carotid artery stenosis measured by CSS and by carotid CTA(CSS reported percentage of carotid stenosis within 30 days of carotid CTA)
  • Difference between percent carotid artery stenosis measured by CSS and carotid angiogram(CSS reported percentage of carotid stenosis within 30 days of carotid angiogram)
  • Difference between percent carotid artery stenosis measured by CSS and by carotid MRA(CSS reported percentage of carotid stenosis within 30 days of carotid MRA)

Study Sites (1)

Loading locations...

Similar Trials